eClinical Solutions Market

The global eClinical solutions market is projected to reach USD 25.22 billion by 2030, growing from USD 13.18 billion in 2025, at a CAGR of 13.9% during the forecast period. Increased operational costs and strict regulatory requirements for clinical research studies are the main reasons for the growth of this market, along with other factors, such as the adoption of new software solutions for clinical research, favorable government funding for clinical trials, the need for better data standardization, and the growth of research and development of drugs through biotech-pharma companies, which further drives the market. However, several factors are likely to constrain market growth. These factors include excessively high implementation costs of eClinical solutions, a low supply of skilled professionals, and an insufficient level of awareness among the researchers.

Prominent players in the eClinical solutions market include Medidata (Dassault Systèmes Company) (France), Veeva Systems (US), IQVIA (US), ICON Plc (Ireland), Oracle (US), among others. These companies adopted strategies, such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions, to strengthen their market presence in the eClinical solutions market. In October 2024, Medidata launched Medidata Rave Lite, which simplifies data collection and management, enabling research teams to conduct trials efficiently while ensuring compliance with regulatory standards. Likewise, in November 2024, it partnered with Bioforum to strengthen its partnership to improve data management, optimize trial efficiency, and support the development of innovative treatments.

To know about the assumptions considered for the study download the pdf brochure

Medidata (Dassault Systèmes Company) enables end-to-end global clinical data capture and management with vast functionality. This gives an additional variety of functionalities for a wide range of different clinical study needs, ensuring a strong market position and high industry competence. The company covers organic development through advanced creation and updating of solutions. In October 2024, the company launched the Medidata Rave Lite solution. This initiative simplifies the process of data collection and management and allows the conduct of trials by research teams effectively while ensuring compliance with regulatory requirements. This solution aims to enhance accessibility and scalability for a broader range of clinical studies. Medidata also uses other inorganic techniques, such as partnerships, collaborations, and acquisitions, to strengthen its market position.

Veeva Systems is a leading provider of industry cloud solutions to the global life sciences sector. The company’s products include cloud software, data, and business consulting, all of which are targeted to customers' individual needs across their most strategic business areas, from R&D to commercialization. Veeva’s solutions help life sciences organisations create and launch products more rapidly and efficiently, market and sell more successfully, and comply with regulatory requirements. The company’s revenue is split between two product categories: Commercial Solutions and R&D Solutions. Commercial Solutions comprise Veeva Commercial Cloud and Veeva Claims Solutions, whereas R&D Solutions include Veeva Development Cloud, Veeva RegulatoryOne, and Veeva QualityOne Solutions. The Veeva Development Cloud includes application suites for clinical, regulatory, quality, and safety tasks in life sciences organisations, all built on Veeva's proprietary Veeva Vault platform.

IQVIA has a strong presence in the healthcare industry and is recognized as a leader in life sciences research and commercial outsourcing. The company focuses on extending eClinical solutions offerings that help IQVIA achieve a differential advantage. This kind of model decentralizes the respective company’s operation, which, in turn, increases the quality of the data, brings enhancement in the experience level maintained by the patients, and shortens clinical trials. IQVIA’s leading position in the eClinical solutions marketplace was further defined by acquisitions and collaborations. The company has recently ramped up its needed R&D investment to furnish a service portfolio focused on expanding and launching in China, India, Russia, Turkey, and Japan.

Related Reports:

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (CRO, Pharma, Biotech, Medtech), Regulatory, Al, Growth, Market Size - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com